Stocks and Investing Stocks and Investing
Mon, March 3, 2014
Fri, February 28, 2014
Thu, February 27, 2014
Wed, February 26, 2014
Tue, February 25, 2014
Mon, February 24, 2014
Fri, February 21, 2014
Thu, February 20, 2014
Wed, February 19, 2014
Tue, February 18, 2014
Mon, February 17, 2014
Fri, February 14, 2014
Thu, February 13, 2014
Wed, February 12, 2014
Tue, February 11, 2014
Mon, February 10, 2014
Fri, February 7, 2014
Thu, February 6, 2014
Wed, February 5, 2014
Tue, February 4, 2014
Mon, February 3, 2014
Fri, January 31, 2014
Thu, January 30, 2014
Wed, January 29, 2014
Tue, January 28, 2014
Mon, January 27, 2014
Fri, January 24, 2014
Thu, January 23, 2014
Wed, January 22, 2014
Tue, January 21, 2014
Fri, January 17, 2014
Thu, January 16, 2014
Wed, January 15, 2014
Tue, January 14, 2014
Mon, January 13, 2014
Fri, January 10, 2014
Thu, January 9, 2014
Wed, January 8, 2014
Tue, January 7, 2014
Mon, January 6, 2014
Sun, January 5, 2014
Fri, January 3, 2014
Thu, January 2, 2014
Tue, December 31, 2013
Fri, December 27, 2013
Tue, December 24, 2013
Mon, December 23, 2013
Fri, December 20, 2013
Thu, December 19, 2013

Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $415 on, Jan 28th, 2014


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-415-on-jan-28th-2014.html
Published in Stocks and Investing on Friday, October 25th 2024 at 4:09 GMT by   Print publication without navigation


Andrew Peters of Deutsche Bank, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $340 to $415 on, Jan 28th, 2014.

Andrew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Christopher Marai of "Nomura" Initiated at Strong Buy and Held Target at $368 on, Wednesday, January 8th, 2014
  • Christopher Raymond of "Piper Sandler" Initiated at Buy on, Tuesday, November 26th, 2013
  • Evan Seigerman of "Credit Suisse" Maintained at Buy and Held Target at $290 on, Friday, November 22nd, 2013